Sitemap
- Startpagina
- Dermatologie
- Atopisch Eczeem
- Artikelen
- Patiënt Prominent – Samen Vooruit in de Dermatologie
- Spotlight on AD—the role key cytokines play and a look at the factors that contribute to this condition
- Exploring the Unique Characteristics of Atopic Dermatitis (AD) and Prurigo Nodularis (PN)
- Presentatie Aanvraag | Kinderarts
- Type 2 inflammatie in Atopisch Eczeem herkennen
- Long-Term Efficacy and Safety of Dupixent in Moderate-to-Severe Atopic Dermatitis: 5-Year Open-Label Extension Study Results1
- Cumulative Life Course Impairment (CLCI) in Atopic Dermatitis
- Herziening NVDV-richtlijn Constitutioneel Eczeem
- Type 2 inflammatie vormt de basis van comorbiditeit bij atopisch eczeem
- PROMs: De stem van uw patiënt centraal
- BioDay-register: 5 jaar ervaring met dupilumab
- Advancing the treatment: Meeting the challenge of uncontrolled Atopic Dermatitis (AD) and Prurigo Nodularis (PN)
- Publicaties op basis van Nederlandse RWE veiligheids- en effectiviteitsdata in de behandeling van atopisch eczeem
- Sleep and QOL: the full impact on patients coping with the burden of AD
- Type 2 inflammatie in Atopisch Eczeem
- Presentatie Aanvraag | Dermatoloog
- Underneath the skin
- Hulpmiddelen
- Events
- Educatie
- DermTalks Podcasts – Atopic Dermatitis in Special Populations
- Managing Atopic Dermatitis in Patients with Comorbidities
- Managing Pediatric Atopic Dermatitis
- Webinar - Zoveel meer dan alleen maar eczeem!
- Antwoorden kinderartsen puzzelboek
- Webinarserie - DermaDialogen
- Webinar - Van data naar doen!
- Transforming Atopic Dermatitis Care: The Impact of Early Treatment – A DermTalks Webinar
- Atopic Dermatitis in Melanin-Rich Skin – A DermTalks Webinar
- Podcastserie: Type 2 inflammatoire aandoeningen bij de kinderen
- Introduction to hand and foot dermatitis
- Onder de Eczeemhuid - Podcastserie van de VMCE
- Podcast - Constitutioneel eczeem door dermatologen Marjolein de Bruin-Weller en Marlies de Graaf
- Hot topics in atopic dermatitis: Longterm Control in AD
- Hot topics in atopic dermatitis: Hear it from the experts
- Managing Atopic Dermatitis in the Elderly
- Managing Atopic Dermatitis During Pregnancy and Breastfeeding
- Artikelen
- Prurigo Nodularis
- Overige onderwerpen
- Atopisch Eczeem
- Zeldzame Ziekten
- Pompe
- Gaucher
- Artikelen
- Educatie
- Lunch & Learn Webinar #2 - Biomarkers in Lysosomal Storage Diseases
- The Hematology Podcast - Season 3
- The Hematology Podcast - Season 2
- Curious Cases - Daag uzelf uit met complexe hematologische casussen
- The Hematology Podcast - Season 1
- The Hematology Podcast - Season 4
- Addressing Bone Disease in Lysosomal storage diseases
- Fabry
- Respiratoire aandoeningen
- COPD
- Chronische rinosinusitis met neuspoliepen (CRSwNP)
- Artikelen
- Educatie
- Polyp Gossip – Episode 7
- Polyp Gossip – Episode 2
- Polyp Gossip – Episode 1
- Polyp Gossip – Episode 5
- Polyp Gossip – Episode 3
- Polyp Gossip – Episode 6
- Lunch & Learn Aanvraag – Leven zonder reuk: meer dan een verstopte neus
- Polyp Gossip
- Rhino Rounds International 2025
- Rhino Rounds International 2024 - Interview
- Polyp Gossip – Episode 4
- Astma
- Dyslipidemie
- Diabetes
- Diabetes type 1
- Artikelen
- Time to Rethink T1D?
- Understanding Autoimmune T1D & The Value of Early Detection
- No More or Less Severe – Living with Diabetes is Always There
- The Complex Burden of Autoimmune Type 1 Diabetes
- Does your patient have an existing autoimmune condition? Check for autoimmune type 1 diabetes!
- Autoimmune Type 1 Diabetes
- Real-life stories from people living with autoimmune T1D
- Can autoimmune type 1 diabetes be detected years before symptom onset?
- Detectability of Autoimmune Type 1 Diabetes
- How Nicole Turned Her Diagnosis into Strength and Inspiration for Herself and Others
- How should individuals with positive autoimmune T1D autoantibodies be monitored over time?
- When a Child Gets Autoimmune Type 1 Diabetes
- Early detection of autoimmune type 1 diabetes could reduce the risk of diabetic ketoacidosis
- Global Developments in Early Detection of Autoimmune Type 1 Diabetes
- Need to identify risk of developing autoimmune type 1 diabetes? Test for autoantibodies!
- Infographic: Impact of Type 1 Diabetes Diagnosis
- Events
- Educatie
- Artikelen
- Diabetes type 2
- Artikelen
- Switching from other basal insulins to Toujeo® (Insulin Glargine)
- How Does Glycaemic Control Impact Complications in Type 2 Diabetes?
- Why is Glycaemic Control in Type 2 Diabetes Still a Challenge?
- When to Initiate Basal Insulin?
- Glycaemic Targets and Vascular Complications in Type 2 Diabetes: What Are the Thresholds?
- The RESTORE-G Real World Evidence Study
- BRIGHT publication
- Is Glycemic Control the Key to Preventing Long-term Complications in Type 2 Diabetes?
- Events
- Educatie
- Artikelen
- Dyslipidemie
- Diabetes type 1
- Cardiologie
- Dyslipidemie
- Artikelen
- Prevent the Event
- Lipid management in patients with diabetes mellitus
- 146 for Lipid Management After ACS
- Why choose PRALUENT®?
- Cardiovascular diseases (CVDs) are the leading cause of death globally
- Approach for patients with coronary artery disease (CAD): focus on LDL-C control
- Acute LDL-C reduction post ACS: Strike early and strike strong: From evidence to clinical practice
- Educatie
- Preventive Cardiology: Key Insights from Professor Michal Vrablik
- Why Don’t We Strike Early, Strike Strong?
- A phase III randomized trial evaluating alirocumab 300 mg every 4 weeks as monotherapy or add-on to statin: ODYSSEY CHOICE I
- Understanding Cardiovascular Risk and Prevention: Insights from Professor Pasquale Perrone-Filardi
- Artikelen
- Dyslipidemie
- Oncologie
- Vaccins
- Hematology
- Andere onderwerpen
- Hematologie
- Verworven Trombotische Trombocytopenie Purpura (ATTP)
- Producten
- Therapeutische gebieden
- Sitemap
- Registreren
- Log in
- Gebruiksvoorwaarden
- Data Privacy
- Cookieverklaring